Published in J Inherit Metab Dis on March 12, 2015
Newborn screening for Krabbe disease in New York State: the first eight years' experience. Genet Med (2016) 0.97
Lymphocyte Galactocerebrosidase Activity by LC-MS/MS for Post-Newborn Screening Evaluation of Krabbe Disease. Clin Chem (2017) 0.81
Newborn screening for Krabbe's disease. J Neurosci Res (2016) 0.80
Sulfatide Analysis by Mass Spectrometry for Screening of Metachromatic Leukodystrophy in Dried Blood and Urine Samples. Clin Chem (2015) 0.79
Should states adopt newborn screening for early infantile Krabbe disease? Genet Med (2016) 0.76
Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease. J Neurosci Res (2016) 0.75
LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease. PLoS One (2017) 0.75
Biomarkers in Lysosomal Storage Diseases. Diseases (2016) 0.75
Psychosine, a marker of Krabbe phenotype and treatment effect. Mol Genet Metab (2017) 0.75
Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med (2005) 4.26
Ion suppression in mass spectrometry. Clin Chem (2003) 3.55
Newborn screening for Krabbe disease: the New York State model. Pediatr Neurol (2009) 2.88
Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science (1984) 1.68
Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase. Biochem Biophys Res Commun (1972) 1.44
Implementation of newborn screening for Krabbe disease: population study and cutoff determination. Clin Biochem (2009) 1.19
Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004-2007). J Inherit Metab Dis (2007) 1.18
Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease. Clin Chim Acta (2013) 1.08
Sphingolipid extraction and analysis by thin-layer chromatography. Methods Enzymol (2000) 1.02
Globoid cell leukodystrophy: deficiency of lactosyl ceramide beta-galactosidase. Proc Natl Acad Sci U S A (1974) 0.98
The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3β and deregulation of molecular motors. J Neurosci (2013) 0.97
Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture. J Lipid Res (2013) 0.86
Detection of the neurotoxin psychosine in samples of peripheral blood: application in diagnostics and follow-up of Krabbe disease. Arch Pathol Lab Med (2012) 0.77
Quantification of psychosine in the serum of twitcher mouse by LC-ESI-tandem-MS analysis. J Pharm Biomed Anal (2013) 0.77
Quantitative analysis of free sphingoid bases in the brain and spinal cord tissues by high-performance liquid chromatography with a fluorescence detection. J Chromatogr B Biomed Sci Appl (1998) 0.75
Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem (2004) 5.26
Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med (2004) 4.15
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med (2011) 3.21
Newborn screening for Krabbe disease: the New York State model. Pediatr Neurol (2009) 2.88
Plasma homocysteine in obstructive sleep apnoea. Eur Heart J (2004) 2.85
Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med (2014) 2.62
A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab (2009) 2.25
Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots. Clin Chem (2008) 2.03
Medium-chain acyl-CoA dehydrogenase deficiency in gene-targeted mice. PLoS Genet (2005) 2.03
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med (2002) 1.96
Fatty acid oxidation disorders. Annu Rev Physiol (2002) 1.96
Determination of total homocysteine, methylmalonic acid, and 2-methylcitric acid in dried blood spots by tandem mass spectrometry. Clin Chem (2010) 1.94
Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clin Chem (2003) 1.92
Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab (2004) 1.91
Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders. Clin Chem (2008) 1.71
Exome sequencing reveals a novel mutation for autosomal recessive non-syndromic mental retardation in the TECR gene on chromosome 19p13. Hum Mol Genet (2011) 1.70
Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. Gastroenterology (2005) 1.69
Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children. Genet Med (2010) 1.69
Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet (2004) 1.66
Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. Science (2012) 1.65
Abnormal concentrations of esterified carnitine in bile: a feature of pediatric acute liver failure with poor prognosis. Hepatology (2005) 1.60
Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood (2002) 1.59
Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia. Glycobiology (2005) 1.56
Cutaneous porphyrias part I: epidemiology, pathogenesis, presentation, diagnosis, and histopathology. Int J Dermatol (2013) 1.53
The subunit composition of the human NADH dehydrogenase obtained by rapid one-step immunopurification. J Biol Chem (2003) 1.48
Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. Mol Genet Metab (2009) 1.44
Expanded newborn screening identifies maternal primary carnitine deficiency. Mol Genet Metab (2006) 1.44
Enhanced interpretation of newborn screening results without analyte cutoff values. Genet Med (2012) 1.44
Chronic management and health supervision of individuals with propionic acidemia. Mol Genet Metab (2011) 1.41
Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function. Hepatology (2009) 1.41
High-throughput immunoassay for the biochemical diagnosis of Friedreich ataxia in dried blood spots and whole blood. Clin Chem (2013) 1.39
DTI registration in atlas based fiber analysis of infantile Krabbe disease. Neuroimage (2011) 1.38
A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet (2004) 1.38
Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver. Liver Transpl (2005) 1.36
Neurologic considerations in propionic acidemia. Mol Genet Metab (2011) 1.34
Acylcarnitine profile analysis. Genet Med (2008) 1.33
Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid beta-oxidation. Mol Genet Metab (2005) 1.33
Acute management of propionic acidemia. Mol Genet Metab (2011) 1.30
Simplified newborn screening protocol for lysosomal storage disorders. Clin Chem (2011) 1.29
Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting. J Inherit Metab Dis (2010) 1.26
Natural history of propionic acidemia. Mol Genet Metab (2011) 1.24
A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency. Mol Genet Metab (2007) 1.23
Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS. Stem Cells (2013) 1.22
The frequency of short-chain acyl-CoA dehydrogenase gene variants in the US population and correlation with the C(4)-acylcarnitine concentration in newborn blood spots. Mol Genet Metab (2003) 1.21
Improving newborn screening laboratory test ordering and result reporting using health information exchange. J Am Med Inform Assoc (2010) 1.17
The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level. Hum Genet (2008) 1.16
Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Mol Genet Metab (2003) 1.16
Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry. Clin Chim Acta (2010) 1.16
Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Québec. Mol Genet Metab (2012) 1.13
Hyperhomocysteinemia inhibits post-injury reendothelialization in mice. Cardiovasc Res (2005) 1.12
DDOST mutations identified by whole-exome sequencing are implicated in congenital disorders of glycosylation. Am J Hum Genet (2012) 1.09
Allelic diversity in MCAD deficiency: the biochemical classification of 54 variants identified during 5 years of ACADM sequencing. Mol Genet Metab (2010) 1.09
Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease. Clin Chim Acta (2013) 1.08
A disservice to advances in newborn genetic screening: comment on Timmermans and Buchbinder. J Health Soc Behav (2011) 1.07
Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management. Pediatr Res (2005) 1.06
Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometry. Pediatrics (2003) 1.05